CRISPR Therapeutics AG Insider Trading for December 2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CRISPR Therapeutics AG.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in CRISPR Therapeutics AG for December 2016.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 23 2016 | CRSP | CRISPR Therapeutic ... | Woiwode Thomas | Director | Option Exercise | C | 0.00 | 5,774 | 0 | 0 | |
Dec 23 2016 | CRSP | CRISPR Therapeutic ... | Woiwode Thomas | Director | Option Exercise | C | 0.00 | 13,180 | 0 | 0 | |
Dec 23 2016 | CRSP | CRISPR Therapeutic ... | Woiwode Thomas | Director | Option Exercise | C | 0.00 | 5,210 | 0 | 0 | |
Dec 23 2016 | CRSP | CRISPR Therapeutic ... | Woiwode Thomas | Director | Option Exercise | C | 0.00 | 173,167 | 0 | 0 | |
Dec 23 2016 | CRSP | CRISPR Therapeutic ... | Woiwode Thomas | Director | Option Exercise | C | 0.00 | 1,454 | 0 | 0 | |
Dec 23 2016 | CRSP | CRISPR Therapeutic ... | Woiwode Thomas | Director | Option Exercise | C | 0.00 | 231,077 | 0 | 0 | |
Dec 23 2016 | CRSP | CRISPR Therapeutic ... | Woiwode Thomas | Director | Option Exercise | C | 0.00 | 73,704 | 0 | 0 | |
Dec 23 2016 | CRSP | CRISPR Therapeutic ... | Woiwode Thomas | Director | Option Exercise | C | 0.00 | 168,224 | 0 | 0 | |
Dec 23 2016 | CRSP | CRISPR Therapeutic ... | Woiwode Thomas | Director | Option Exercise | C | 0.00 | 66,490 | 0 | 0 | |
Dec 23 2016 | CRSP | CRISPR Therapeutic ... | Woiwode Thomas | Director | Option Exercise | C | 0.00 | 2,210,417 | 0 | 0 | |
Dec 23 2016 | CRSP | CRISPR Therapeutic ... | Woiwode Thomas | Director | Option Exercise | C | 0.00 | 19,524 | 0 | 0 | |
Dec 23 2016 | CRSP | CRISPR Therapeutic ... | Woiwode Thomas | Director | Option Exercise | C | 0.00 | 3,100,477 | 0 | 0 | |
Dec 23 2016 | CRSP | CRISPR Therapeutic ... | Woiwode Thomas | Director | Option Exercise | C | 0.00 | 2,754 | 0 | 0 | |
Dec 23 2016 | CRSP | CRISPR Therapeutic ... | Woiwode Thomas | Director | Option Exercise | C | 0.00 | 437,247 | 0 | 0 | |
Dec 23 2016 | CRSP | CRISPR Therapeutic ... | Woiwode Thomas | Director | Option Exercise | A | 14.00 | 30,000 | 420,000 | 60,000 | |
Dec 23 2016 | CRSP | CRISPR Therapeutic ... | Woiwode Thomas | Director | Buy | C | 0.00 | 5,774 | 0 | 79,478 | 73.7 K to 79.5 K (+7.83 %) |
Dec 23 2016 | CRSP | CRISPR Therapeutic ... | Woiwode Thomas | Director | Buy | C | 0.00 | 73,704 | 0 | 73,704 | 0 to 73.7 K |
Dec 23 2016 | CRSP | CRISPR Therapeutic ... | Woiwode Thomas | Director | Buy | P | 14.00 | 4,583 | 64,162 | 185,987 | 181.4 K to 186 K (+2.53 %) |
Dec 23 2016 | CRSP | CRISPR Therapeutic ... | Woiwode Thomas | Director | Buy | C | 0.00 | 13,180 | 0 | 181,404 | 168.2 K to 181.4 K (+7.83 %) |
Dec 23 2016 | CRSP | CRISPR Therapeutic ... | Woiwode Thomas | Director | Buy | C | 0.00 | 168,224 | 0 | 168,224 | 0 to 168.2 K |
Dec 23 2016 | CRSP | CRISPR Therapeutic ... | Woiwode Thomas | Director | Buy | C | 0.00 | 5,210 | 0 | 71,700 | 66.5 K to 71.7 K (+7.84 %) |
Dec 23 2016 | CRSP | CRISPR Therapeutic ... | Woiwode Thomas | Director | Buy | C | 0.00 | 66,490 | 0 | 66,490 | 0 to 66.5 K |
Dec 23 2016 | CRSP | CRISPR Therapeutic ... | Woiwode Thomas | Director | Buy | P | 14.00 | 60,219 | 843,066 | 2,443,803 | 2.4 M to 2.4 M (+2.53 %) |
Dec 23 2016 | CRSP | CRISPR Therapeutic ... | Woiwode Thomas | Director | Buy | C | 0.00 | 173,167 | 0 | 2,383,584 | 2.2 M to 2.4 M (+7.83 %) |
Dec 23 2016 | CRSP | CRISPR Therapeutic ... | Woiwode Thomas | Director | Buy | C | 0.00 | 2,210,417 | 0 | 2,210,417 | 0 to 2.2 M |
Dec 23 2016 | CRSP | CRISPR Therapeutic ... | Woiwode Thomas | Director | Buy | P | 14.00 | 602 | 8,428 | 24,334 | 23.7 K to 24.3 K (+2.54 %) |
Dec 23 2016 | CRSP | CRISPR Therapeutic ... | Woiwode Thomas | Director | Buy | C | 0.00 | 1,454 | 0 | 23,732 | 22.3 K to 23.7 K (+6.53 %) |
Dec 23 2016 | CRSP | CRISPR Therapeutic ... | Woiwode Thomas | Director | Buy | C | 0.00 | 19,524 | 0 | 22,278 | 2.8 K to 22.3 K (+708.93 %) |
Dec 23 2016 | CRSP | CRISPR Therapeutic ... | Woiwode Thomas | Director | Buy | C | 0.00 | 2,754 | 0 | 2,754 | 0 to 2.8 K |
Dec 23 2016 | CRSP | CRISPR Therapeutic ... | Woiwode Thomas | Director | Buy | P | 14.00 | 95,596 | 1,338,344 | 4,104,045 | 4 M to 4.1 M (+2.38 %) |
Dec 23 2016 | CRSP | CRISPR Therapeutic ... | Woiwode Thomas | Director | Buy | C | 0.00 | 231,077 | 0 | 4,008,449 | 3.8 M to 4 M (+6.12 %) |
Dec 23 2016 | CRSP | CRISPR Therapeutic ... | Woiwode Thomas | Director | Buy | C | 0.00 | 3,100,477 | 0 | 3,777,372 | 676.9 K to 3.8 M (+458.04 %) |
Dec 23 2016 | CRSP | CRISPR Therapeutic ... | Woiwode Thomas | Director | Buy | C | 0.00 | 437,247 | 0 | 676,895 | 239.6 K to 676.9 K (+182.45 %) |
Dec 23 2016 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Option Exercise | C | 0.00 | 5,774 | 0 | 0 | |
Dec 23 2016 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Option Exercise | C | 0.00 | 13,180 | 0 | 0 | |
Dec 23 2016 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Option Exercise | C | 0.00 | 5,210 | 0 | 0 | |
Dec 23 2016 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Option Exercise | C | 0.00 | 173,167 | 0 | 0 | |
Dec 23 2016 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Option Exercise | C | 0.00 | 1,454 | 0 | 0 | |
Dec 23 2016 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Option Exercise | C | 0.00 | 231,077 | 0 | 0 | |
Dec 23 2016 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Option Exercise | C | 0.00 | 73,704 | 0 | 0 | |
Dec 23 2016 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Option Exercise | C | 0.00 | 168,224 | 0 | 0 | |
Dec 23 2016 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Option Exercise | C | 0.00 | 66,490 | 0 | 0 | |
Dec 23 2016 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Option Exercise | C | 0.00 | 2,210,417 | 0 | 0 | |
Dec 23 2016 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Option Exercise | C | 0.00 | 19,524 | 0 | 0 | |
Dec 23 2016 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Option Exercise | C | 0.00 | 3,100,477 | 0 | 0 | |
Dec 23 2016 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Option Exercise | C | 0.00 | 2,754 | 0 | 0 | |
Dec 23 2016 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Option Exercise | C | 0.00 | 437,247 | 0 | 0 | |
Dec 23 2016 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Option Exercise | A | 14.00 | 30,000 | 420,000 | 60,000 | |
Dec 23 2016 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Buy | C | 0.00 | 5,774 | 0 | 79,478 | 73.7 K to 79.5 K (+7.83 %) |
Dec 23 2016 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Buy | C | 0.00 | 73,704 | 0 | 73,704 | 0 to 73.7 K |
Dec 23 2016 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Buy | P | 14.00 | 4,583 | 64,162 | 185,987 | 181.4 K to 186 K (+2.53 %) |
Dec 23 2016 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Buy | C | 0.00 | 13,180 | 0 | 181,404 | 168.2 K to 181.4 K (+7.83 %) |
Dec 23 2016 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Buy | C | 0.00 | 168,224 | 0 | 168,224 | 0 to 168.2 K |
Dec 23 2016 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Buy | C | 0.00 | 5,210 | 0 | 71,700 | 66.5 K to 71.7 K (+7.84 %) |
Dec 23 2016 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Buy | C | 0.00 | 66,490 | 0 | 66,490 | 0 to 66.5 K |
Dec 23 2016 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Buy | P | 14.00 | 60,219 | 843,066 | 2,443,803 | 2.4 M to 2.4 M (+2.53 %) |
Dec 23 2016 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Buy | C | 0.00 | 173,167 | 0 | 2,383,584 | 2.2 M to 2.4 M (+7.83 %) |
Dec 23 2016 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Buy | C | 0.00 | 2,210,417 | 0 | 2,210,417 | 0 to 2.2 M |
Dec 23 2016 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Buy | P | 14.00 | 602 | 8,428 | 24,334 | 23.7 K to 24.3 K (+2.54 %) |
Dec 23 2016 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Buy | C | 0.00 | 1,454 | 0 | 23,732 | 22.3 K to 23.7 K (+6.53 %) |
Dec 23 2016 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Buy | C | 0.00 | 19,524 | 0 | 22,278 | 2.8 K to 22.3 K (+708.93 %) |
Dec 23 2016 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Buy | C | 0.00 | 2,754 | 0 | 2,754 | 0 to 2.8 K |
Dec 23 2016 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Buy | P | 14.00 | 95,596 | 1,338,344 | 4,104,045 | 4 M to 4.1 M (+2.38 %) |
Dec 23 2016 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Buy | C | 0.00 | 231,077 | 0 | 4,008,449 | 3.8 M to 4 M (+6.12 %) |
Dec 23 2016 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Buy | C | 0.00 | 3,100,477 | 0 | 3,777,372 | 676.9 K to 3.8 M (+458.04 %) |
Dec 23 2016 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Buy | C | 0.00 | 437,247 | 0 | 676,895 | 239.6 K to 676.9 K (+182.45 %) |